首页> 外文期刊>clinical nuclear medicine >Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the Lungs
【24h】

Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the Lungs

机译:Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the Lungs

获取原文
           

摘要

Kinetics of Tc-99m MIBI uptake was studied in 19 patients with lung lesions (6 benign, 13 malignant). Two dynamic studies were acquired after the I.V. injection of 10-15mCi (370-550 MBq); the first was every second for 60 seconds, followed by a second one every minute for 30 minutes. Delayed images were acquired at two and three hours. By assigning regions of interest (ROI) over the lung lesions (TR), contralateral normal lung (NL) and the heart (Ht), time activity curves (TAC) were generated and time to peak activity was calculated as well as the ratios of TRsol;NL, Htsol;TR and Htsol;NL. The Htsol;NL ratio was also assessed in five patients referred with diagnosis of ischaemic heart disease (IHD) for myocardial imaging.There was a localized increase of Tc-99m MIBI uptake in ten patients with untreated malignant tumours of the lung. No localized uptake was found in one patient with untreated poorly differentiated squamous cell carcinoma, two treated lung cancer and four patients with non-malignant lesions of the lungs. Two patients with fibrosing alveolitis showed diffuse increase lung uptake. In all positive studies peak tumour was reached within the first minute. There was no statistical difference in the ratio of Htsol;NL between all groups except in patients with fibrosing alveolitis. There was no significant difference between the ratios TRsol;NL, Htsol;R and Htsol;NL at 5-10 minutes and 25-30 minutes. The ratio of TRsol;NL at 25-30 minutes was 1.58 plusmn; 0.36 in the positive cases versus 1 plusmn; 0.22 in the negative ones. The mean Htsol;TR ratio was 1.7 plusmn; 0.45 in the positive ones versus 2.14 plusmn; 0.54 in those with benign lesions of the lungs.This initial study demonstrates the uptake of Tc-99m MIBI in malignant tumours with prominent difference between benign and malignant lesions. It is evident that radiotherapy inhibits this uptake.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号